503Studio Masterclass: Writing for Theatre, Alice Birch
A Masterclass session with Alice Birch on writing for Theatre.
THIS COURSE IS CURRENTLY SOLD OUT.
To be added to our waiting list, please sign up here (please note that some places have been held off sale to prioritise Share the Drama beneficiaries – see below)
Thanks to our Share The Drama scheme, we want to make sure those of you who are struggling in the current climate can still take part in our Writers Programme. While we prioritise anyone who is long term unemployed and/or claiming benefits, we’re also offering subsidies if you’re in financial difficulty as a result of the Covid-19 crisis.
To express interest in a bursary place through our Share The Drama scheme, please sign up here. If you would prefer to speak directly to a member of our team about your circumstance or to ask for more information about this scheme, please contact us.
Time: 10am – 12.30pm
Running time of workshop: 2.5 hours – delivered online. Maximum class sizes are 14. A portion of spaces have been reserved for Share the Drama places.
To sign up for advanced booking for future iterations of the 503Studio: Writers Programme, please join the waiting list here.
Alice Birch is the winner of the Arts Foundation Award for Playwriting 2014, the co-winner of the George Devine Award for Most Promising Playwright 2014 and winner of the Susan Smith Blackburn Award in 2018 after being shortlisted in 2012 and 2015. Theatre includes: Anatomy of a Suicide (Royal Court), Revolt. She Said. Revolt Again. (RSC/Soho Rep NYC), Ophelias Zimmer (Royal Court/Schaubuhne Theater Berlin), We Want You to Watch (National Theatre), Little Light (Orange Tree), Little on the inside (Almeida/Clean Break) and Many Moons (Theatre 503). Film includes Lady Macbeth (BBC/BFI/Creative England) which was the winner of the International Critic’s Prize (FIPRESCI Prize) at San Sebastian Film Festival 2016, the Best First Feature at Zurich Film Festival 2016 and the winner of Best Screenplay at Turin Film Festival 2016.
There are currently no news articles for this show!